Indivior Pharmaceuticals Inc (INDV)
INDV Stock Price Chart
Explore Indivior Pharmaceuticals Inc interactive price chart. Choose custom timeframes to analyze INDV price movements and trends.
INDV Company Profile
Discover essential business fundamentals and corporate details for Indivior Pharmaceuticals Inc (INDV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Dec 2014
Employees
1.03k
Website
https://www.indivior.comCEO
Joseph J. Ciaffoni
Description
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
INDV Financial Timeline
Browse a chronological timeline of Indivior Pharmaceuticals Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is $0.88, while revenue estimate is $306.55m.
Earnings released on 30 Apr 2026
EPS came in at $0.96 surpassing the estimated $0.64 by +50.00%, while revenue for the quarter reached $317.00m , beating expectations by +16.19%.
Earnings released on 26 Feb 2026
EPS came in at $0.82 surpassing the estimated $0.65 by +26.15%, while revenue for the quarter reached $358.00m , beating expectations by +17.14%.
Earnings released on 30 Oct 2025
EPS came in at $0.72 surpassing the estimated $0.38 by +89.47%, while revenue for the quarter reached $314.00m , beating expectations by +2.54%.
Earnings released on 31 Jul 2025
EPS came in at $0.51 surpassing the estimated $0.26 by +96.15%, while revenue for the quarter reached $302.00m , beating expectations by +18.32%.
Earnings released on 24 Apr 2025
EPS came in at $0.41 surpassing the estimated $0.22 by +86.36%, while revenue for the quarter reached $266.00m , beating expectations by +9.78%.
Earnings released on 20 Feb 2025
EPS came in at $0.32 matching the estimated $0.32, while revenue for the quarter reached $299.00m , beating expectations by +24.51%.
Earnings released on 24 Oct 2024
EPS came in at $0.54 surpassing the estimated $0.31 by +74.19%, while revenue for the quarter reached $307.00m , beating expectations by +17.88%.
Earnings released on 25 Jul 2024
EPS came in at $0.44 surpassing the estimated $0.40 by +10.00%, while revenue for the quarter reached $299.61m , beating expectations by +3.54%.
Earnings released on 25 Apr 2024
EPS came in at $0.37 falling short of the estimated $0.42 by -11.90%, while revenue for the quarter reached $282.74m , missing expectations by -5.68%.
Earnings released on 22 Feb 2024
EPS came in at $0.43 surpassing the estimated $0.28 by +53.57%, while revenue for the quarter reached $300.65m , beating expectations by +8.93%.
Earnings released on 9 Nov 2023
EPS came in at $0.34 surpassing the estimated $0.30 by +13.33%, while revenue for the quarter reached $261.20m , missing expectations by -3.44%.
Earnings released on 27 Jul 2023
EPS came in at $0.39 surpassing the estimated $0.22 by +77.27%, while revenue for the quarter reached $279.85m , beating expectations by +9.74%.
Earnings released on 27 Apr 2023
EPS came in at $0.40 , while revenue for the quarter reached $256.80m , missing expectations by -15.15%.
Earnings released on 16 Feb 2023
EPS came in at $0.27 , while revenue for the quarter reached $241.00m , beating expectations by +8.07%.
Earnings released on 27 Oct 2022
EPS came in at $0.29 , while revenue for the quarter reached $232.00m , beating expectations by +6.91%.
Stock split effective on 10 Oct 2022
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Jul 2022
EPS came in at $0.30 , while revenue for the quarter reached $221.00m , beating expectations by +0.91%.
INDV Stock Performance
Access detailed INDV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
